We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Trial of Home Versus Clinic-based Screening for Sexually Transmitted Infections

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01184157
First Posted: August 18, 2010
Last Update Posted: August 18, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Washington University School of Medicine
August 17, 2010
August 18, 2010
August 18, 2010
Not Provided
Not Provided
Number of tests received
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Randomized Trial of Home Versus Clinic-based Screening for Sexually Transmitted Infections
Randomized Trial of Home Versus Clinic-based Screening for Sexually Transmitted Infections in Long-Acting Reversible Contraceptive Users
This study randomizes women using long-acting reversible methods of contraception to home-based STD screening through the mail compared to screening available in a clinical setting. We hypothesize that women randomized to home-based screening will be more likely to complete screening.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Screening
  • Chlamydia
  • Gonorrhea
  • Behavioral: Home screening
  • Behavioral: Clinic screening
  • Experimental: Home
    Home-based STI screening using self-obtained vaginal swabs and postal return of samples.
    Intervention: Behavioral: Home screening
  • Active Comparator: Clinic
    Receive STI screening in a clinical setting such as a private physician or clinic.
    Intervention: Behavioral: Clinic screening
Graseck AS, Secura GM, Allsworth JE, Madden T, Peipert JF. Home compared with clinic-based screening for sexually transmitted infections: a randomized controlled trial. Obstet Gynecol. 2010 Dec;116(6):1311-8. doi: 10.1097/AOG.0b013e3181fae60d.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Participant in Contraceptive CHOICE cohort study
  • Using a long-acting reversible method of contraception
  • Completed baseline clinical survey in the Contraceptive CHOICE cohort study

Exclusion Criteria:

  • Living outside the United States at time of annual STI screening
Sexes Eligible for Study: Female
14 Years to 45 Years   (Child, Adult)
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01184157
07-0256
No
Not Provided
Not Provided
Jeffrey Peipert, MD PhD, Washington University School of Medicine
Washington University School of Medicine
Not Provided
Principal Investigator: Jeffrey Peipert, MD, PhD Washington University School of Medicine
Washington University School of Medicine
August 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP